Bropharma ApS: Financial statements 2023
CVR: 38596330
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Bropharma ApS (CVR 38596330) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -164,166 and a net result of DKK -20,534 compared with DKK -272,439 the year before. Equity in the 2023 report amounted to DKK 106,076. The solvency ratio was 50.2%.
- Gross Profit
- DKK -164,166
- Profit/Loss
- DKK -20,534
- Equity
- DKK 106,076
- Total Assets
- DKK 211,209
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -164 t. | -21 t. | 106 t. | - |
| 2022 | - | -349 t. | -272 t. | -1.5 mio. | - |
| 2021 | - | -541 t. | -386 t. | -1.2 mio. | - |
| 2020 | - | -454 t. | -400 t. | -792 t. | - |
| 2019 | - | -583 t. | -489 t. | -383 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Bropharma ApS has published its annual report for 2022. Gross profit came to DKK -349,110, and the net result was DKK -272,439.
About Bropharma ApS
Bropharma ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2017. The company is registered under the industry Detailhandel med bad- og køkkenelementer mv.. The management consists of Maj-Britt Amy Hjort Fielden. The company is owned by HJORT PETERSEN HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 18,436 and a net result of DKK 33,217 compared with DKK -85,587 the year before. Equity in the 2025 report amounted to DKK 53,706.